SCHEMBL24348056

SCHEMBL24348056

CCc1cnc(OCc2nc(C)c(-c3cccc(-c4cc(F)c5nn[nH]c5c4)n3)s2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BPGM P07738 5/20 0.54
▸ RXRA P19793 14/20 0.35
▸ GRIN1 Q05586 14/20 0.35
▸ GRIN2B Q13224 14/20 0.35
▸ KDM4E B2RXH2 1/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ PLK4 O00444 1/20 0.33
▸ DYRK3 O43781 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ ROS1 P08922 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PRKACA P17612 1/20 0.33
▸ RPS6KB1 P23443 1/20 0.33
▸ MARK3 P27448 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ CSNK1A1 P48729 1/20 0.33
▸ CSNK1D P48730 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24349408 0.92 BPGM (0.64) BPGMRXRAGRIN1GRIN2BKDM4E
SCHEMBL24348054 0.90 BPGM (0.55) BPGMRXRAGRIN1GRIN2BKDM4E
SCHEMBL24348060 0.90 BPGM (0.54) BPGMRXRAGRIN1GRIN2BKDM4E
SCHEMBL24348977 0.89 BPGM (0.54) BPGMRXRAGRIN1GRIN2BKDM4E
SCHEMBL24348976 0.87 BPGM (0.52) BPGMKDM4ECDC7PLK4DYRK3
SCHEMBL24349263 0.85 BPGM (0.49) BPGMRXRAGRIN1GRIN2BKDM4E
SCHEMBL26704333 0.84 BPGM (0.64) BPGMRXRAGRIN1GRIN2BKDM4E
SCHEMBL24348041 0.83 BPGM (0.47) BPGMKDM4ECDC7PLK4DYRK3
SCHEMBL24348995 0.81 BPGM (0.46) BPGMRXRAGRIN1GRIN2BKDM4E
SCHEMBL26704310 0.81 BPGM (0.46) BPGMKDM4ECDC7PLK4DYRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022056449-A1 COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE GENZYME CORPORATION (US) 2022-03-17 — — WO disclosed
Send feedback